Journal
ARCHIVES OF MEDICAL RESEARCH
Volume 44, Issue 7, Pages 488-494Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.arcmed.2013.10.004
Keywords
Anacardic acid; Quorum-sensing inhibitors; Amphiptetygium adstringens; Antiquorum; Antimicrobial plant
Categories
Funding
- PAPIIT [IN 2095512]
- Instituto de Ciencia y Tecnologia del Distrito Federal (ICyTDF)
- Consejo Nacional de Ciencia y Tecnologia (CONACYT)
- SEP/CONACyT [152794]
- [PICSA 11-78]
- [HIM/2011/081]
Ask authors/readers for more resources
Background and Aims. Quorum sensing (QS) is a process of bacterial cell-cell communication that controls a large number of systems affecting pathogenicity. Interrupting this communication system can provide nonvirulent pathogenic bacteria. The aim of this study was to evaluate the anti-quorum sensing (anti-QS) potential of an anacardic acids mixture isolated from Amphipterygium adstringens, a medicinal plant known as cuachalalate, to prevent the onset of bacterial infections as an alternate to antibiotics. Methods. Initially we investigated the anti-QS activity of A. adstringens hexane extract (HE) by the inhibition of violacein production in Chromobacterium violaceum. From the active HE, an anacardic acid mixture (AAM) was obtained. The anti-quorum sensing activity of AAM was investigated by the rhamnolipid and pyocyanin production constraint as well as decrease of elastase activity, all being quorum sensing-controlled virulence factors expressed in the pathogenic bacteria Pseudomonas aeruginosa. Results. HE induced a 91.6% of inhibition of the violecin production at 55 mu g/mL concentration, whereas AAM showed 94% of inhibition at 166 mu g/mL. In both cases, inhibition of violacein production did not affect the viability of the bacterium. AAM inhibited pyocyanin (86% at 200 mu g/mL) and rhamnolipid (91% at 500 mu g/mL) production in a dose/response form and decrease the elastase (75% at 500 mu g/mL) activity in P. aeruginosa without affecting its development. Conclusions. Because an anacardic acids mixture isolated from A. adstringens demonstrated anti-QS, it could be further exploited for novel molecules to treat the emerging infections of antibiotic-resistant bacterial pathogens. (C) 2013 IMSS. Published by Elsevier Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available